Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.10 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.286NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.369NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.69NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.26NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.87NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.39.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GA.4.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HK.3.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.73 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.60 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.124.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GS.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.13.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GJ.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XYNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.1.1.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.5.2.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.45NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
GP.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.4.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBQNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.6.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CR.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21584South Korea
BV.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GA.4.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AD.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.201NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
W.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GK.2.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.560NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.164NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.275NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.58NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.81NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.419NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.151NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used